Alpine Woods Capital Investors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Alpine Woods Capital Investors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,000	Closed	-$416K	–	166
2023 Q2	$416K	Hold	5,000	–	–	0.07%	127
2023 Q1	$381K	Hold	5,000	–	–	0.06%	142
2022 Q4	$415K	Sell	5,000 -28,230	-85%	-$2.29M	0.06%	142
2022 Q3	$2.64M	Hold	33,230	–	–	0.36%	84
2022 Q2	$2.47M	Hold	33,230	–	–	0.31%	101
2022 Q1	$2.99M	Hold	33,230	–	–	0.31%	100
2021 Q4	$3.72M	Hold	33,230	–	–	0.37%	93
2021 Q3	$4.18M	Hold	33,230	–	–	0.45%	81
2021 Q2	$4.5M	Hold	33,230	–	–	0.47%	79
2021 Q1	$4.51M	Hold	33,230	–	–	0.5%	72
2020 Q4	$4.68M	Sell	33,230 -6,770	-17%	-$867K	0.57%	62
2020 Q3	$4.46M	Sell	40,000 -300	-0.7%	-$33.6K	0.67%	44
2020 Q2	$4.51M	Hold	40,300	–	–	0.87%	24
2020 Q1	$3.12M	Buy	40,300 +28,000	+228%	+$2.48M	0.69%	33
2019 Q4	$1.17M	Sell	12,300 -5,000	-29%	-$432K	0.22%	103
2019 Q3	$1.32M	Hold	17,300	–	–	0.24%	86
2019 Q2	$1.52M	Hold	17,300	–	–	0.31%	82
2019 Q1	$1.57M	Hold	17,300	–	–	0.34%	72
2018 Q4	$1.24M	Buy	+17,300	New	+$1.39M	0.3%	82
2017 Q4	–	Sell	-97,300	Closed	-$8.42M	–	470
2017 Q3	$8.42M	Hold	97,300	–	–	0.43%	85
2017 Q2	$7.51M	Hold	97,300	–	–	0.4%	86
2017 Q1	$6.75M	Sell	97,300 -108,000	-53%	-$7.25M	0.36%	97
2016 Q4	$12.2M	Buy	205,300 +51,000	+33%	+$3.15M	0.67%	47
2016 Q3	$10.2M	Buy	+154,300	New	+$9.55M	0.57%	64

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Alpine Woods Capital Investors's XBI Position: Q3 2023 in Review

Alpine Woods Capital Investors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 5,000 shares — an estimated $416K sold.

Alpine Woods Capital Investors first reported a position in XBI in Q3 2016 and held it in 24 quarters. The position peaked at $12.2M in Q4 2016. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Alpine Woods Capital Investors reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Alpine Woods Capital Investors sold 5,000 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $416K.
Alpine Woods Capital Investors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 24 quarters.
Alpine Woods Capital Investors's State Street SPDR S&P Biotech ETF position peaked at $12.2M in Q4 2016.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Alpine Woods Capital Investors's 13F filing for Q3 2023, filed 8 Nov 2023.